Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 in Children
Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 Associated Encephalopathy/Encephalitis and Multi-systemic Inflammatory Syndrome in Children
Sponsor: Chang Gung Medical Foundation
Listed as NCT05576714, this observational or N/A phase trial focuses on COVID-19-Associated Encephalitis and Multisystem Inflammatory Syndrome in Children and remains ongoing. Sponsored by Chang Gung Medical Foundation, it has been updated 4 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
4 versions recorded-
Aug 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2022 — Jul 2024 [monthly]
Recruiting
First recorded
Aug 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chang Gung Medical Foundation
- Chi Mei Medical Hospital
- Mackay Memorial Hospital
- National Cheng-Kung University Hospital
- National Health Research Institutes, Taiwan
- National Science and Technology Council
- National Taiwan University Hospital
- Tri-Service General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .